Evidence map›Paper›PMID 42320043›Full record

ArticleJMIR research protocols2026

Mapping Prevalence, Diagnostics, and Evidence Gaps of Cryptosporidium in Southeast Asia Across Human, Animal, and Environmental Domains: Protocol for a One Health Scoping Review.

Elad I Stotland, John Barlow, Andrea J Etter

Abstract read
In one paragraph

Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elad I StotlandDepartment of Animal and Veterinary Sciences, College of Agriculture and Life Sciences, University of Vermont, Burlington, VT, United States.ORCID 0009-0005-7673-2915
John Barlow *Department of Animal and Veterinary Sciences, College of Agriculture and Life Sciences, University of Vermont, Burlington, VT, United States.ORCID 0000-0002-7815-9383
Andrea J Etter *Department of Nutrition and Food Sciences, College of Agriculture and Life Sciences, University of Vermont, 353 MLS Carrigan Wing, 109 Carrigan Drive, Burlington, VT, 05405, United States, 1 802-656-0541.ORCID 0000-0002-0204-0239

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cryptosporidium is a waterborne and zoonotic protozoan parasite that causes cryptosporidiosis, a diarrheal disease that disproportionately affects young children and immunocompromised individuals in low- and middle-income settings. In Southeast Asia, ecological diversity, agricultural intensification, and uneven sanitation infrastructure create overlapping transmission pathways across human, animal, and environmental domains. Despite a growing body of regional literature, the structure of the evidence base and its utility for surveillance and control have not been comprehensively evaluated using an integrated One Health lens. Objective: This protocol outlines the methodology for a scoping review mapping the published literature on Cryptosporidium in Southeast Asia, characterizing the distribution of evidence on prevalence, diagnostic methods, species and genotype diversity, and environmental, food-related, and socioeconomic determinants of transmission across human, animal, and environmental domains. Methods: The review follows the Arksey and O'Malley framework, refined by Levac and colleagues and the Joanna Briggs Institute, and is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). Five databases were searched from inception through September 30, 2024: PubMed, Embase, CABI Digital Library, Cochrane Library, and Index Medicus for the South-East Asia Region (IMSEAR), supplemented by backward citation tracking and targeted searches of organizational websites. Studies were included if they reported primary data on Cryptosporidium in human, animal, or environmental samples collected from one or more of the eleven Southeast Asian countries and addressed prevalence, diagnostic methods, or transmission risk factors. Reviews, editorials, letters, conference abstracts, and non-English publications were excluded. No formal risk-of-bias assessment was conducted, consistent with scoping review methodology. Data were organized thematically and synthesized descriptively, with findings presented across One Health domains using tables, figures, and maps generated in RStudio (version 2023.09.1+494). Results: Database searches retrieved 889 records before deduplication. After removing 177 duplicates, 711 unique records underwent title and abstract screening. Of 333 full-text articles assessed for eligibility, 176 studies were included in the final synthesis, representing nine of eleven Southeast Asian countries and spanning 1985 to 2024. Data extraction and analysis are complete. The manuscript reporting the full findings is being prepared for submission to a peer-reviewed journal. Conclusions: This scoping review provides a comprehensive cross-domain mapping of evidence on Cryptosporidium in Southeast Asia. The findings are expected to identify structural gaps in the regional evidence base, characterize diagnostic heterogeneity and its implications for surveillance utility, and support the development of integrated One Health surveillance strategies in the region.

Indexed as

CryptosporidiosisCryptosporidiumAnimalsAsia, SoutheasternEvidence GapsHumansOne HealthPrevalenceScoping Reviews as TopicASEANAssociation of Southeast Asian NationscryptosporidiosisCryptosporidiumdiagnostic methodsenvironmental surveillanceOne Healthscoping reviewSoutheast Asiawaterborne diseasezoonosis

Identifiers

PMID42320043
PMCPMC13282039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.